LPLasse Pakanen

Lasse Pakanen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lasse Pakanen has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sudden cardiac death due to aortic stenosis

    by Matti Riihiniemi, Elias Törmäkangas, Jarkko Piuhola, Matti Niemelä, Lassi Mäntyniemi, Juha Vähätalo, Anette Eskuri, Ida King, Lasse Pakanen, Juha Perkiömäki, et al.

    Background: Characteristics of subjects with sudden cardiac death (SCD) due to aortic stenosis (AS) are not well defined. Aim of this study was to present clinical and autopsy findings of SCD subjects in whom AS was determined to be the cause of death. Methods: Study population was based on the Finnish Genetic Study of Arrhythmic Events (Fingesture), a large registry which included 5869 consecutive subjects of autopsy-verified SCD between 1998 and 2017. The cause of death was determined based on medicolegal investigation combining data from medical records, police reports and autopsy. Clinical history, ECGs and echocardiographic data were reviewed when available. Results: Valvular heart disease (VHD) was determined to be the cause of SCD in 64 subjects (1.1%), where AS was the most frequent cause of SCD due to VHD (68.8%). The average age in victims of SCD due to AS was 67.5±12.1 years and 79.5% were male. Documented angina or dyspnoea prior to SCD due to AS was rare (6.8% and 4.5%, respectively), and over half of the SCD subjects (54.5%) did not have a previously established diagnosis of AS. Almost all subjects (93.2%) with SCD due to AS had cardiac hypertrophy and myocardial fibrosis at autopsy. Conclusions: VHD is a rare cause of SCD, where AS is the dominant underlying pathology. SCD due to AS occurs often without previous diagnosis. Near-universal presence of cardiac hypertrophy and myocardial fibrosis at autopsy supports the role of advanced myocardial disease in the pathogenesis of SCD due to AS.

  • Open Access

    First Occurrence of Fatal Intoxication Involving Methiodone (IC‐26) in Finland; a Medicolegal Autopsy Case Report

    by Lasse Pakanen, Raimo A. Ketola, Pirkko Kriikku

    Methiodone (IC‐26) is a non‐fentanyl novel synthetic opioid which has recently been detected in drug seizures in Europe. There is still limited data about the drug in published toxicological case work, both in non‐fatal and fatal cases. We present a medicolegal autopsy case report on a fatal intoxication in an individual undergoing opioid agonist treatment. A methiodone concentration of 1.5 mg/L was detected in the femoral vein blood and was considered the primary intoxicant causing death. This is the first published occurrence of fatal intoxication involving methiodone in Finland and emphasizes the need for constant monitoring of substance abuse during substitution therapy, including the potential use of novel synthetic opioids.


  • Open Access

    Wischnewsky spots relate to ketosis/ketoacidosis regardless of the cause of death – A systematic autopsy study

    by Lasse Pakanen, Kie Horioka, Raimo Ketola, Pirkko Kriikku, Katja Porvari


  • Open Access

    Left ventricular ejection fraction and myocardial fibrosis in sudden cardiac death

    by Harri Silvola, Lauri Holmström, Lasse Pakanen, Ida King, Anette Eskuri, Jani Tikkanen, Juha Perkiömäki, Heikki Huikuri, Juhani Junttila

    Aims: Left ventricular ejection fraction (LVEF) remains the key determinant in the evaluation for the risk of sudden cardiac death (SCD). Myocardial fibrosis has gained increasingly more interest in the context of various myocardial diseases. We determined the spectrum of LVEF and evaluated the association between myocardial fibrosis and pre-SCD LVEF in a population-based SCD cohort. Methods and results: The Fingesture study and clinical data have been collected from consecutive autopsy-verified SCD victims from Northern Finland between 1998 and 2017 (n = 5869). The cause of death was verified in medicolegal autopsy in all subjects. Electronic health records were used to identify those with pre-mortem echocardiography data. The extent of myocardial fibrosis at autopsy was characterized macroscopically and from histology samples. The LVEF recorded median 2 years (interquartile range 1–5) prior to SCD was evaluated in 716 SCD subjects. Proportional LVEF values were as follows: 62.7% (n = 449) normal LVEF (≥50%), 21.9% (n = 157) mildly reduced LVEF (36–49%), and 15.4% (n = 110) severely reduced LVEF (≤35%). At autopsy 19.6% (n = 140) had substantial, 53.8% (n = 386) moderate, and 22.1% (n = 158) mild fibrosis, and 4.5% (n = 32) had no myocardial fibrosis. The extent of myocardial fibrosis and LVEF had poor correlation (Spearman’s ρ 0.21, CI 0.141–0.285, P < 0.001). Only 21.4% of those with substantial fibrosis at autopsy had LVEF ≤35%. Conclusion: The proportion of SCD subjects with LVEF ≤35% is low, and the prevalence of myocardial fibrosis is high. The LVEF has a weak correlation with the extent of myocardial fibrosis. Our study suggests that LVEF is a poor surrogate of myocardial fibrosis in SCD victims.


  • Open Access

    Primordial Symptoms and ECG Among Sudden Cardiac Death Victims Due to Primary Myocardial Fibrosis

    by H. Silvola, L. Pakanen, L. Holmström, J. S. Perkiömäki, M. A. E Eskuri, H. V. Huikuri, M. J. Junttila

    Background: Sudden cardiac death (SCD) remains a major cause of death despite progress in prevention and intervention of cardiac diseases. The most common cause of nonischemic SCD in young individuals in Northern Finland is primary myocardial fibrosis (PMF).Methods: Fingesture study consists of 5869 prospectively collected subjects with SCD from Northern Finland collected from 1998 to 2017. Nonischemic etiology was the cause of SCD in 1477 (25%) subjects out of which primary myocardial fibrosis was the cause of SCD in 184 (12%) subjects (65% men, median age 55 ± 16 years). We examined the ante mortem ECG and medical history of the subjects to discover preceding symptoms and ECG changes.Results: Prior health care contact in electronic health record system (EHR) was found for 89 (48%) subjects and ECG was available for 52 (28%) subjects. Both medical history and ECG were available for 20 subjects (11%). We observed that transient loss of consciousness (TLOC) was the most common symptom recorded and was reported by 33 (37%) subjects. ECG was abnormal in 38 (73%) subjects. Fragmented QRS (fQRS) complex was found in 26 (50%) subjects. Vast majority, 87% of subjects had either TLOC or abnormal ECG. Only seven subjects with ECG or EHR history available had normal ECG and did not have TLOC.Conclusions: Many SCD victims with primary myocardial fibrosis had abnormal ECG or history of TLOC. The results suggest that the combination should generate careful cardiovascular examination to detect underlying myocardial disease and possibly prevent SCD.


  • Open Access

    Amphiregulin is overexpressed in human cardiac tissue in hypothermia deaths; associations between the transcript and stress hormone levels in cardiac deaths

    by Katja Porvari, Kie Horioka, Helena Kaija, Lasse Pakanen

    Amphiregulin (AREG) is a growth factor linked to cardioprotection and heart pathology during myocardial stress. Our aim was to investigate cardiac AREG expression, its potential as a postmortem hypothermia marker and its possible stress hormone dependency in different types of deaths. Heart RNA was isolated from hypothermic, cardiac and non-cardiac deaths. Relative AREG mRNA levels and urine stress hormone concentrations were measured by qPCR and enzyme-linked immunosorbent assays from eight different death cause groups. Receiver operating characteristic curve was used to evaluate a cut-off point for AREG expression as a hypothermia marker. Regulatory elements were predicted by PROMO. The AREG mRNA levels were significantly higher in hypothermic deaths than in most cardiac and non-cardiac deaths. AREG expression indicated hypothermic deaths with nearly 70% sensitivity and specificity. However, high expression levels were also detected in non-ischaemic deaths. The highest concentrations of adrenaline and cortisol were detected in hypothermic deaths, while the highest noradrenaline concentrations associated with atherosclerotic heart disease (AHD) deaths with acute myocardial infarction and trauma deaths. There were no significant correlations between stress hormones and AREG mRNA in hypothermic and non-cardiac deaths, whereas moderate-to-high associations were detected in cardiac deaths. Putative response elements for cortisol and catecholamines were found in AREG. Severe hypothermia activates cardiac AREG expression practicable as a postmortem hypothermia marker. Cortisol and catecholamines may act as transcriptional modifiers of this gene, especially in long-term ischaemic heart disease. However, the exact role of these hormones in upregulation of AREG during hypothermia remains unclear.


  • Open Access

    Primordial symptoms and electrocardiogram among sudden cardiac death victims due to primary myocardial fibrosis

    by Silvola H, Lasse Pakanen, Lauri Holmström, Juha Perkiömäki, Heikki Huikuri, Juhani Junttila

    Background. Sudden cardiac death (SCD) remains a major cause of death despite progress in prevention and intervention of cardiac diseases. The most common cause of non-ischemic SCD in young individuals in Northern Finland is primary myocardial fibrosis (PMF). Methods. Fingesture study consists of 5,869 systematically autopsied subjects with SCD from Northern Finland collected from 1998 to 2017. Nonischemic etiology was the cause of SCD in 1477 (25%) subjects out of which primary myocardial fibrosis was the cause of SCD in 184 (12%) subjects (65% men, median age 55±16 years). Medico-legal autopsies in PMF subjects showed no other noncardiac organ changes or prior diseases that could have caused myocardial fibrosis detected at gross dissection and histological analyses. We examined the ante mortem ECG and medical history of the subjects to discover preceding symptoms and ECG changes. Results. Prior health care contact in electronic health record system was found for 89 (48%) subjects and ECG was available for 52 (28%) subjects; 20 subjects both medical history and ECG were available. We observed that transient loss of consciousness (TLOC) was the most common symptom recorded and was reported by 33 (37%) subjects. ECG was abnormal in 38 (73%) subjects. Fragmented QRS (fQRS) complex was found in 26 (50%) subjects. Other ECG findings were prolonged QTc (>450ms in men and >470ms in women) in 10 (19%), T-inversions in 4 (8%), pathological Q-waves in 3 (6%), and prolonged QRS (> 110 ms) in 3 subjects. Vast majority, 87% of subjects had either TLOC or abnormal ECG. Only 7 subjects with ECG or ERS history available had normal ECG and did not have previous TLOC. Conclusions. Most subjects with PMF had abnormal ECG or previous TLOC. The results suggest that the combination should generate careful cardiovascular examination in order to detect underlying myocardial disease and possibly prevent SCD.

  • Open Access

    COVID-19 vaccination was a rare potential etiology for cause of death after medicolegal autopsy. A Finnish nationwide study

    by Lasse Pakanen, Tuomo Nieminen, Paula Kuvaja, Hanna Nohynek, Sirkka Goebeler, Miia Artama, Petteri Hovi

    COVID-19 vaccinations began globally at the end of 2020. By the end of 2021, 9.8 million doses were given in Finland. Regarding safety, most vaccine-related adverse reactions have been mild, but serious and lethal ones have also occurred. Autopsies in post vaccination deaths may give insight to the extent of fatal health conditions with potential COVID-19 vaccine etiology and provide new hypotheses of possible causalities between vaccination and severe health conditions. We searched the complete documentation on all medicolegal autopsies in Finland between December 2020 and December 2021 to assess how often the basis for autopsy was a suspected fatal adverse reaction to COVID-19 vaccination, and whether vaccination remained a potential etiology for any health condition determined as a cause of death after the autopsy. We linked register-based data on individual COVID-19 vaccination course and pre-existing health conditions. We found 428 autopsy cases with a mention of COVID-19 vaccination, and prior to autopsy, vaccination was suspected to play a part in 76 deaths. Post autopsy, a forensic pathologist considered vaccination as a potential etiology in five underlying and seven contributory causes of death. These included seven thromboembolisms, two diabetic ketoacidoses, one myocarditis, one acute pancreatitis, and one eosinophilic granulomatosis with polyangiitis. In relation to the number of vaccinations within Finland, a suspicion of vaccine-related serious adverse reaction was rarely an indication for medicolegal autopsy. Even less frequently was vaccination considered to play a part in the process leading to death, although considerable doubt remains in the accuracy of individual considerations, and autopsy cannot definitively confirm causality between vaccination and death. Regarding vaccination safety, continuing evaluation of suspected vaccine-related deaths is essential, and an autopsy should be part of the investigation when such a suspicion arises.

  • Open Access

    Spontaneous Cardiac Tamponade as a Cause of Sudden Unexpected Death With Focus on Coronary Aneurysms

    by Antti Eranti, Lasse Pakanen, Juha Vähätalo, Heikki V. Huikuri, M. Juhani Junttila

  • Open Access

    Primary myocardial fibrosis — a distinct entity characterized by heterogeneous histology

    by Lasse Pakanen, Henrik Appel, Anne Ahtikoski, Pernille Heimdal Holm, Mervi Kreus, Kristine Boisen Olsen, Jytte Banner, Bo Gregers Winkel, Heikki Huikuri, Riitta Kaarteenaho, et al.